Evaluation of de novo donor specific antibodies after kidney transplantation in the era of donor-derived cell-free DNA
BackgroundDonor-derived cell-free DNA (dd-cfDNA) is a promising non-invasive biomarker for detecting graft injury in solid organ transplant recipients. Elevated dd-cfDNA levels are strongly associated with rejection and graft injury, especially antibody-mediated rejection (ABMR). While de novo donor...
Saved in:
Main Authors: | Yuan Tian, Lukas Frischknecht, Anna Mallone, Fabian Rössler, Thomas Schachtner, Jakob Nilsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1530065/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
γδ T Cells’ Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models
by: Xavier Charmetant, et al.
Published: (2025-01-01) -
Daratumumab followed by tocilizumab for treatment of late antibody-mediated rejection in renal transplant recipients with high or moderate levels of de novo donor-specific antibodies: a pilot study
by: Zhiliang Guo, et al.
Published: (2025-01-01) -
Successful desensitization of donor-specific antibodies in a single cord blood transplant recipient
by: Mégane Tanguay, et al.
Published: (2025-12-01) -
Combination of Hotspot Mutations With Methylation and Fragmentomic Profiles to Enhance Multi‐Cancer Early Detection
by: Thi Hue Hanh Nguyen, et al.
Published: (2025-01-01) -
Quantifying the ability of the CF2H group as a hydrogen bond donor
by: Matthew E. Paolella, et al.
Published: (2025-01-01)